Form EFFECT Kairos Pharma, LTD.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 23, 2026 9:00 A.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- J. Colby Williams to Succeed Jeffrey Welch as Executive Vice President and General Counsel at Red Rock Resorts
- Black Hills Corp. Requests Rate Review in Colorado
- Fox River Provides Reminder To Vote And Updated Dissent Rights
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share